ClaroNav has secured quasi-equity financing from the Growth and Transition Capital team of BDC Capital, the investment arm of BDC. ClaroNav plans on using these funds to expand the global marketing, training, sales, and support activities of its flagship Navident product.
Navident uses volumetric medical images (CBCT) and real-time movement tracking to help dentists place implants more precisely, less invasively, and more efficiently, ClaroNav says. It has regulatory clearance in the United States, Europe, Canada, and other countries.
“Recently, ClaroNav introduced product innovations which received an enthusiastic response from the market. Navident is now a superior product with a proven ability to meet market needs,” said Claudio Gatti, cofounder and co-CEO of ClaroNav.
“Navident is already the most widely used technology of its kind in the world,” said Enes Kula, director, growth and transition capital for the greater Toronto area, BDC Capital. “We expect the use of Navident to soar as more patients around the world continue requesting dental implants.”
Related Articles
TruAbutment to Host First Symposium
Implant Anchored in the Zygomatic Bone for High Torque
Implant Systems Offer Identical Internal Hex Connections
